PPADS, a purinergic antagonist reduces Fos expression at spinal cord level in a mouse model of mononeuropathy.

Borsani, E; Albertini, R; Colleoni, M; Sacerdote, P; Trovato, A E; Lonati, C; Labanca, M; Panerai, A E; Rezzani, R; Rodella, L F

Borsani, E; Albertini, R; Colleoni, M; Sacerdote, P; Trovato, A E; Lonati, C; Labanca, M; Panerai, A E; Rezzani, R; Rodella, L F.

Affiliation

Borsani E; Department of Biomedical Sciences and Biotechnologies, Division of Human Anatomy, University of Brescia, Brescia, Italy.

Brain Res ; 1199: 74-81, 2008 Mar 14.

Article in En | MEDLINE | ID: mdl-18302958

Subject(s)

Down-Regulation/drug effects; Oncogene Proteins v-fos/metabolism; Platelet Aggregation Inhibitors/administration & dosage; Pyridoxal Phosphate/analogs & derivatives; Sciatic Neuropathy/pathology; Spinal Cord/metabolism; Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia/drug therapy; Hyperalgesia/physiopathology; Male; Mice; Mice, Inbred C57BL; Pain Measurement/methods; Pain Threshold/drug effects; Pyridoxal Phosphate/administration & dosage; Sciatic Neuropathy/drug therapy; Sciatic Neuropathy/physiopathology; Spinal Cord/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridoxal Phosphate / Spinal Cord / Platelet Aggregation Inhibitors / Down-Regulation / Oncogene Proteins v-fos / Sciatic Neuropathy Limits: Animals Language: En Journal: Brain Res Year: 2008 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google